Should You Buy Data#3 Limited At This Share Price?

By ,

What happened to the DTL share price?

Data#3 Limited [ASX:DTL] has had its ups and downs over the decade. However, 2015 has been a rewarding year for DTL equity investors so far.

In a recent strategy study at Port Philip Publishing, I found my way to many small-cap tech companies such as Data#3. Many of these companies produced a great return and I was able to make a list.

If you look at the Australian tech sector by breaking it down into smaller industries, you can find interesting companies such as ICS Global Ltd in the health tech segment. In the hardware space, Codan Ltd has been interesting to watch.

Of course, most high return tech companies fall into the software & services category, of which Data#3 is a part.

What should you do with DTL shares now?

When I looked at those tech companies that paid a dividend, a very interesting relationship emerged. There is a semi-strong inverse relationship between dividend yield and 12 month revenue growth.

What does that mean? It means if you pick a company that will pay a great dividend, it will have a lower growth in revenue.

That could make sense if more mature companies with lower level growth paid more dividends. But there was no evidence showing an inverse relationship between market caps and revenue growth, so that theory does not stand.

When it comes to return on equity, high revenue growth in a small-cap tech company does not necessarily lead to a very high appreciation in its share price.

But in my mind, a strong bottom-line growth is still going to be the backbone for any company in the medium run.

This means investors need to be mindful of the trade-off between dividends and bottom-line growth when it comes to small-cap tech companies.

Ken Wangdong
Emerging Market Analyst, New Frontier Investor

Join Money Morning on Google+

About Money Morning

At Money Morning our aim is simple: to give you intelligent and enjoyable commentary on the most important stock market news and financial information of the day - and tell you how to profit from it. We know the best investments are often the hardest to find. So that's why…

Bubs Announces $68 Million Capital Raise

[ASX:BUB] is rattling the can to raise $68 million to support ‘growth opportunities.’

Bubs (ASX:BUB) Shares up on US Supply Deal Update

Infant nutrition producer Bubs Australia [ASX:BUB] came out with another supplier update today, signing supply agreements with two more US retailers.

NeuRizer [ASX:NRZ] Shares Soar on $1.5 Billion Binding Offtake

NeuRizer [ASX:NRZ] opened 35% higher on Monday after announcing a binding $1.5 billion offtake agreement with Daelim.

[WATCH] Closing Bell — In the Eye of the Storm

It’s a sea of bad news out there at the moment. Equities have cracked and they are continuing to drift lower.

AVZ Minerals Extends Voluntary Suspension

Lithium developer AVZ Minerals [ASX:AVZ] has extended its voluntary suspension on Friday as it continues to work through regulatory and ownership issues concerning its Manono Lithium Project.

OpenPay Shares Jump 25% as BNPL Firm Pauses US Operations

Openpay Group [ASX:OPY] is suspending its US operations indefinitely and materially reducing its US staff as the buy now, pay later (BNPL) stock continues to scale down to drive down costs.